Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 36, Issue 8, Pages 1620-1630
Publisher
Springer Nature
Online
2011-04-07
DOI
10.1038/npp.2011.43
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
- (2010) Cynthia Shannon Weickert et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia
- (2010) Yang Yang et al. BIOLOGICAL PSYCHIATRY
- Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Psychiatric Symptoms in Overweight People With Schizophrenia
- (2010) Deanna L. Kelly et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- Human brain weight is correlated with expression of the ‘housekeeping genes’ beta-2-microglobulin (β2M) and TATA-binding protein (TBP)
- (2010) P. J. Harrison et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia
- (2010) J. Wong et al. NEUROSCIENCE
- IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA
- (2010) Jenny Ceccarini et al. SCHIZOPHRENIA RESEARCH
- Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
- (2010) Patrik Roser et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- S39-02 Antipsychotic effects of cannabidiol
- (2009) F.M. Leweke et al. EUROPEAN PSYCHIATRY
- Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
- (2009) Q.-R. Liu et al. GENES BRAIN AND BEHAVIOR
- HU210-Induced Downregulation in Cannabinoid CB1 Receptor Binding Strongly Correlates with Body Weight Loss in the Adult Rat
- (2009) Victoria S. Dalton et al. NEUROCHEMICAL RESEARCH
- Risperidone Treatment Increases CB1 Receptor Binding in Rat Brain
- (2009) Anna Secher et al. NEUROENDOCRINOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reliability of Post-Mortem Psychiatric Diagnosis for Neuroscience Research
- (2008) Nina Sundqvist et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain
- (2008) Katrina Weston-Green et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
- (2008) A. Ludanyi et al. JOURNAL OF NEUROSCIENCE
- Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats
- (2008) Jenny L. Wiley et al. NEUROPHARMACOLOGY
- Psychosis Following Anti-Obesity Treatment with Rimonabant
- (2008) Tarik Ugur et al. Obesity Facts
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started